Fullerton A - Search Results

1

Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics.

Kümler I, Sørensen PG, Palshof J, Høgdall E, Skovrider-Ruminski W, Theile S, Fullerton A, Nielsen PG, Jensen BV, Nielsen DL. Kümler I, et al. Among authors: fullerton a. Cancer Chemother Pharmacol. 2019 Jan;83(1):169-178. doi: 10.1007/s00280-018-3720-7. Epub 2018 Nov 8. Cancer Chemother Pharmacol. 2019. PMID: 30406838 Free PMC article. Clinical Trial.

2

An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine.

Kümler I, Eefsen RL, Sørensen PG, Theile S, Fullerton A, Nielsen PG, Jensen BV, Nielsen DL. Kümler I, et al. Among authors: fullerton a. Cancer Chemother Pharmacol. 2019 Aug;84(2):441-446. doi: 10.1007/s00280-019-03819-0. Epub 2019 Apr 4. Cancer Chemother Pharmacol. 2019. PMID: 30949758

3

Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products.

Simonsen L, Fullerton A. Simonsen L, et al. Among authors: fullerton a. Skin Pharmacol Physiol. 2007;20(5):230-6. doi: 10.1159/000104421. Epub 2007 Jun 22. Skin Pharmacol Physiol. 2007. PMID: 17587887

4

The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs.

Jensen M, Groth L, Hølmer G, Hansen HS, Fullerton A. Jensen M, et al. Among authors: fullerton a. Skin Pharmacol Appl Skin Physiol. 2002 Nov-Dec;15(6):401-13. doi: 10.1159/000066453. Skin Pharmacol Appl Skin Physiol. 2002. PMID: 12476014

5

Irritant patch testing: penetration of sodium lauryl sulphate into human skin.

Agner T, Fullerton A, Broby-Johansen U, Batsberg W. Agner T, et al. Among authors: fullerton a. Skin Pharmacol. 1990;3(4):213-7. doi: 10.1159/000210873. Skin Pharmacol. 1990. PMID: 2083078

6

Topical D-vitamins: multiparametric comparison of the irritant potential of calcipotriol, tacalcitol and calcitriol in a hairless guinea pig model.

Fullerton A, Serup J. Fullerton A, et al. Contact Dermatitis. 1997 Apr;36(4):184-90. doi: 10.1111/j.1600-0536.1997.tb00267.x. Contact Dermatitis. 1997. PMID: 9165200

7

Patch test study with calcipotriol ointment in different patient groups, including psoriatic patients with and without adverse dermatitis.

Fullerton A, Avnstorp C, Agner T, Dahl JC, Olsen LO, Serup J. Fullerton A, et al. Acta Derm Venereol. 1996 May;76(3):194-202. doi: 10.2340/0001555576194202. Acta Derm Venereol. 1996. PMID: 8800298 Free article. Clinical Trial.

8

Studies of cutaneous blood flow of normal forearm skin and irritated forearm skin based on high-resolution laser Doppler perfusion imaging (HR-LDPI).

Fullerton A, Rode B, Serup J. Fullerton A, et al. Skin Res Technol. 2002 Feb;8(1):32-40. doi: 10.1046/j.0909-752x.2001.10327.x. Skin Res Technol. 2002. PMID: 12005118 Clinical Trial.

9

Skin irritation typing and grading based on laser Doppler perfusion imaging.

Fullerton A, Rode B, Serup J. Fullerton A, et al. Skin Res Technol. 2002 Feb;8(1):23-31. doi: 10.1034/j.1600-0846.2002.80105.x. Skin Res Technol. 2002. PMID: 12005117 Clinical Trial.

10

The hairless guinea-pig as a model for treatment of cumulative irritation in humans.

Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Andersen F, et al. Among authors: fullerton a. Skin Res Technol. 2006 Feb;12(1):60-7. doi: 10.1111/j.0909-725X.2006.00133.x. Skin Res Technol. 2006. PMID: 16420540 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters